Correction

Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients

Correction Details

Nature of Retraction:

Correction

Retraction Notice:
10.2217/fmb-2022-0014c1

Citations (28)

28
Total Citations
24
Post-Retraction
(85.7%)
4
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
2 Within 30 days
14 Within 1 year
1 After 2+ years
1084 Days since retraction (latest)
Ivermectin and COVID-19
Christopher C Butler, Richard Hobbs, Paul Little et al. (7 authors)
Journal of Infection Open Access
Published: Jun 2025
1084 days after retraction
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses
David Scheim, Peter Parry, David J. Rabbolini et al. (8 authors)
Viruses Open Access
Published: Apr 2024
1 citation
679 days after retraction
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern its Morbidities and Inform Therapeutic Responses. ADDENDUM
David Scheim, Peter Parry, David J. Rabbolini et al. (8 authors)
Unknown Journal Open Access
Published: Apr 2024
4 citations
677 days after retraction
Ivermectin for treatment of COVID-19: A systematic review and meta-analysis
Zhilong Song, Senyuan Shi, Yongli Zhang
Heliyon Open Access
Published: Mar 2024
8 citations
627 days after retraction
Wheel Replacing Pyramid: Better Paradigm Representing Totality of Evidence-Based Medicine
Colleen Aldous, Barry M. Dancis, Jerome Dancis et al. (4 authors)
Annals of Global Health Open Access
Published: Jan 2024
2 citations
567 days after retraction
Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19
David Scheim, Paola Vottero, Alessandro D. Santin et al. (4 authors)
International Journal of Molecular Sciences Open Access
Published: Dec 2023
12 citations
536 days after retraction
Interactions between the principal risk factors for reduction of the eGFR in unvaccinated COVID‑19 survivors: Normal pre-COVID‑19 eGFR, not having diabetes and being hospitalized
José Guzmán-Esquivel, Janet Diaz‐Martinez, Jose G. Ortega-Ortiz et al. (14 authors)
Experimental and Therapeutic Medicine Open Access
Published: Oct 2023
1 citation
504 days after retraction
Role of micronutrients in the modulation of immune system and platelet activating factor in patients with COVID-19; a narrative review
Saeid Doaei, Afrouz Mardi, Maryam Zare
Frontiers in Nutrition Open Access
Published: Sep 2023
8 citations
459 days after retraction
Management of onchocerciasis among adolescents in nkwanta north district of Ghana: Qualitative study of adolescents’ perception, community and health system support
Sitsofe Gbogbo, Hubert Amu, Robert Kokou Dowou et al. (4 authors)
PLoS neglected tropical diseases Open Access
Published: Aug 2023
1 citation
442 days after retraction
COVID-19 Excess Deaths in Peru’s 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State
Juan J Chamie, Jennifer A Hibberd, David Scheim
Cureus Open Access
Published: Aug 2023
6 citations
421 days after retraction
When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples
David Scheim, Colleen Aldous, Barbara Osimani et al. (5 authors)
Journal of Clinical Medicine Open Access
Published: May 2023
4 citations
344 days after retraction
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care
Alberto Palazzuoli, Matteo Beltrami, Peter A. McCullough
Biomedicines Open Access
Published: Mar 2023
5 citations
266 days after retraction
Ivermectin - an antiviral drug for the COVID-19 pandemic?
Christopher Peterson, Anusha Ammu, Audrey Mangwiro et al. (4 authors)
The Southwest Respiratory and Critical Care Chronicles Open Access
Published: Jan 2023
1 citation
225 days after retraction
The Clinical Application of Ivermectin in COVID-19
土玲 车
Open Journal of Natural Science
Published: Jan 2023
202 days after retraction
The Place of Ivermectin in the Management of Covid-19: State of the Evidence
Babalola O.E, Ajayi A.A
Medical Research Archives Open Access
Published: Jan 2023
202 days after retraction
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
Céline Boschi, David Scheim, Audrey Bancod et al. (8 authors)
International Journal of Molecular Sciences Open Access
Published: Dec 2022
33 citations
177 days after retraction
Letter in Reply: More Power To Ivermectin Multidrug Therapy
Sabine Hazan, Sonya Davé, Thomas J. Borody et al. (4 authors)
Future Microbiology
Published: Sep 2022
101 days after retraction
Comment on: ‘Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients’
Esmeralda Garza-Santiago, Alejandro Ortiz-Hernández, Ashuin Kammar‐García et al. (4 authors)
Future Microbiology
Published: Sep 2022
1 citation
95 days after retraction
Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours
Jaqueline C. Stone, Pisirai Ndarukwa, David Scheim et al. (7 authors)
Biologics Open Access
Published: Aug 2022
11 citations
79 days after retraction
Statistical Analysis Methods Applied to Early Outpatient COVID-19 Treatment Case Series Data
Eleftherios Gkioulekas, Peter A. McCullough, Vladimir Zelenko
COVID Open Access
Published: Aug 2022
1 citation
66 days after retraction
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
Milena Soriano Marcolino, Karina Cardoso Meira, Nathália Sernizon Guimarães et al. (9 authors)
BMC Infectious Diseases Open Access
Published: Jul 2022
33 citations
40 days after retraction
Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity
Sabine Hazan
Frontiers in Microbiology Open Access
Published: Jul 2022
1 citation
28 days after retraction
Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey
Estefanía Calvo‐Álvarez, Maria Dolci, Federica Perego et al. (11 authors)
Microorganisms Open Access
Published: Jun 2022
2 citations
11 days after retraction
Nanovectorization of Ivermectin to avoid overdose of drugs
Éric Duverger, Guillaume Herlem, Fabien Picaud
Journal of Biomolecular Structure and Dynamics
Published: Apr 2022
48 days before retraction
A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody
David Scheim
International Journal of Molecular Sciences Open Access
Published: Feb 2022
26 citations
108 days before retraction
Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients
Sabine Hazan, Sonya Davé, Anoja W. Gunaratne et al. (7 authors)
Future Microbiology Open Access
Published: Feb 2022
27 citations
124 days before retraction
Related Records

This article has multiple records in the database due to different notices:

Record #60298
Jan 09, 2025
Retraction
Quick Stats
Total Citations: 28
Years Since Retraction: 3.4 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
The Impact of Ulinastatin on Wound Infection and Healing in…
International Wound Journal • 2 citations
Effect of early treatment with metformin on risk of emergen…
The Lancet Regional Health - Americas • 53 citations
Recruitment of pregnant women to randomised trials of COVID…
European Journal of Obstetrics & Gynecology and Reproductive Biology • 0 citations
Efficacy of combined Sofosbuvir and Daclatasvir in the trea…
Expert Review of Anti-infective Therapy • 35 citations